Cme (CME) Other financing activities (2010 - 2026)

Cme (CME) has reported Other financing activities for 17 consecutive years, with -$200000.0 the latest figure, recorded in Q2 2026.

• Quarterly Other financing activities fell 100.0% year-over-year to -$200000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.8 million (up 3.3% YoY) and the FY2025 annual result came in at -$8.7 million, up 5.43% from the prior year.
• Other financing activities advanced to -$200000.0 in Q2 2026 per CME's latest filing, from -$4.4 million in the prior quarter.
• Over the last five years, Other financing activities for CME reached as high as $3.7 million in Q2 2023 and fell as low as -$8.9 million in Q4 2023.
• A 5-year average of -$2.3 million and a median of -$4.1 million in 2023 frame the typical range for Other financing activities.
• The largest YoY upside for Other financing activities was 1333.33% in 2023 against a maximum downside of 990.0% in 2023.
• Year by year, Other financing activities stood at $1.0 million in 2022, then tumbled by 990.0% to -$8.9 million in 2023, then soared by 97.75% to -$200000.0 in 2024, then soared by 150.0% to $100000.0 in 2025, then tumbled by 300.0% to -$200000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$200000.0, -$4.4 million, and $100000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.